Drug discount agreement for abatacept

Summary

The tender concerns a drug discount agreement for the active substance abatacept for the period 1 September 2026 to 31 August 2028. The bidder should note that DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible and that the specific medicines are defined in Annex 2 to the contract. The exact participation and contract performance requirements must be checked in the tender documents.